http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25092173

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 91
issn 2156-6976
issueIdentifier 1
pageRange 79-91
publicationName American journal of cancer research
startingPage 79
bibliographicCitation Zhai X, You F, Xiang S, Jiang L, Chen D, Li Y, Fan S, Han Z, Zhang T, An G, Zhang B, Chen Y, Meng H, Yang L. MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity. Am J Cancer Res. 2021;11(1):79–91. PMID: 33520361; PMCID: PMC7840711.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_342928538b269b068a0127b0dc16e562
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76b13734eb3e7cc8ce452775be7067ee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4927a2089bc11c923e2b67a19e875d6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7dcffd934f42f6cac4c2fbb83ea74712
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e35ec480fb30563de745f7bb8cf7dd16
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20ed7e1a088e2edcc47f7ef2fe6316c4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98cb368ac0f7bf335db97bd88d744389
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8cdc9754e06ab404b2f5d75837c526a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21f8f6fa89453a6218b1f5221d595e3f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a71326644edbd5f933f4ef8e283d5fa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9c9963fdb9639373e26e6cae3762c59
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9d26f6e1c747df0ed67ec8b8afe67e1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5e813fb75aac24d2597de398f332963
date 2021
identifier https://pubmed.ncbi.nlm.nih.gov/PMC7840711
https://pubmed.ncbi.nlm.nih.gov/33520361
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/38854
https://portal.issn.org/resource/ISSN/2156-6976
language English
source https://pubmed.ncbi.nlm.nih.gov/
title MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0d1c0203c86182a45fb1c6272bbe1d33
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2ab607cfd59f1fbe11e5ae4e6b36603c
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740

Total number of triples: 35.